Esophageal Dysplasia
11
1
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
9.1%
1 terminated out of 11 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Clinical Utility of WATS3D: A 5-Year Prospective Study
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry
trūFreeze® Spray Cryotherapy Patient Registry
WATS3D for the Detection of Esophageal Dysplasia
Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
Endoscopic Sub-mucosal Dissection With the Nestis® Jet Injector System With a Bi-functional Catheter: First Prospective Trial
Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital
Comparison of O-type Hybrid Knife and IT Knife in ESD